跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Astiget - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Astiget
Approved
STANDARD
Astiget
Lloyd Laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
1f0b5a5be9afe8a4
Company
Lloyd Laboratories, Inc
Type
Standard
Approval Details
Approval Id
1f0b5a5be9afe8a4
Drug Approval Philippines Name
Astiget
Product Name
Astiget
Registration Number
DRP-10721-08
Brand Name
Astiget
Generic Name
Dapagliflozin
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Lloyd Laboratories, Inc
Trader
Innogen Pharmaceuticals, Inc
Distributor
Getz Pharma (Phils.), Inc.
Issuance Date
24 June 2024
Expiry Date
11 November 2026
Pharmacologic Category
Blood glucose lowering drug [Sodium-glucose co-transporter 2 (SGLT2) Inhibitor]
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
1f0b5a5be9afe8a4
Type
Standard
Back to Philippines FDA Approvals